Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection

Epidemiology and Infection

Volumn 135, Issue 8, 2007, Pages 1398-1405

  McDonald, Malcolm I ^a,b   Towers, R J ^a   Fagan, P ^a   Carapetis, J R ^a,b   Currie, B J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; M PROTEIN; PROTEIN EMM; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL DNA; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ABORIGINE; AMINO ACID SEQUENCE; ARTICLE; AUSTRALIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENTAL FACTOR; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MOLECULAR TYPING; NONHUMAN; PHARYNGITIS; PYODERMA; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SEQUENCE ANALYSIS; SKIN CULTURE; SKIN INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; THROAT CULTURE; CHILD; CLASSIFICATION; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PHARYNX; RURAL POPULATION; SKIN;

ANTIGENS, BACTERIAL; AUSTRALIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; CARRIER PROTEINS; CHILD; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; PHARYNX; PYODERMA; RHEUMATIC FEVER; RURAL POPULATION; SEQUENCE ANALYSIS, DNA; SKIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 38449087477     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008023     Document Type: Article

References (44)

1. Danchin MH, et al. The burden of group A streptococcal pharyngitis in Melbourne families. Indian Journal of Medical Research 2004; 119: S144-147.
2. Martin JM, et al. Group A streptococci among school-aged children: Clinical characteristics and the carrier state. Pediatrics 2004; 114: 1212-1219.
3. Kumar R, et al. Epidemiology of group A streptococci in a north Indian community. Proceedings of the XVIth Lancefield International Symposium on Streptococci and Streptococcal Diseases. Palm Cove, Queensland, Australia, 2005.
4. McDonald M, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in communities where rheumatic fever is hyperendemic. Clinical Infectious Diseases 2006; 43: 683-689.
5. Brahmadathan KN, et al. Molecular epidemiology of group A streptococcal infections in south Indian children. Proceedings of the XVIth Lancefield International Symposium on Streptococci and Streptococcal Diseases. Palm Cove, Queensland, Australia, 2005.
6. Ogunbi O, Lasi Q, Lawal S. An epidemiological study of beta-hemolytic streptococcal infections in a Nigerian (Lagos) urban population. In: Streptococcal Disease and the Community. Proceedings of the Fifth International Symposium on Streptococcus pyogenes. Amsterdam, the Netherlands: Excerpta Medica, 1972, pp. 144-147.
7. Carapetis JR, et al. The global burden of group A streptococcal diseases. Lancet Infectious Diseases 2005; 5: 685-694.
8. Carapetis JR, Currie BJ, Mathews JD. Cumulative incidence of rheumatic fever in an endemic region: A guide to the susceptibility of the population. Epidemiology and Infection 2000; 124: 239-244.
9. Carapetis JR, Currie B. Group A streptococcus, pyoderma, and acute rheumatic fever. Lancet 1996; 347: 1271-1272.
10. Coburn A, Pauli R. Studies on the immune response of rheumatic subject and its relationship to activity of the rheumatic process IV. Characteristics of strains of hemolytic streptococci, effective and non-effective in initiating rheumatic fever. Journal of Clinical Investigation 1935; 14: 755-762.
11. Seegal D, Earle D. A consideration of certain biological differences between acute glomerulonephritis and rheumatic fever. American Journal of Medical Sciences 1941; 201: 528-539.
12. Rammelkamp CH. Epidemiology of streptococcal infections. Harvey Lectures 1955; 51: 113-142.
13. Stollerman G. Nephritogenic and rheumatogenic group A streptococci. Journal of Infectious Diseases 1969; 120: 258-263.
14. Widdowson JP, Maxted WR, Pinney AM. An M-associated protein antigen (MAP) of group A streptococci. Journal of Hygiene (Cambridge) 1971; 69: 553-564.
15. Maxted WR, et al. The use of serum opacity reaction in the typing of group A streptococci. Journal of Medical Microbiology 1973; 6: 83-90.
16. Rakonjac J, Robbins J, Fischetti V. DNA sequence of the serum opacity factor of group A streptococci: Identification of a fibronectin-binding domain. Infection and Immunity 1995; 63: 622-631.
17. Bessen D, Jones K, Fischetti V. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. Journal of Experimental Medicine 1989; 169: 269-283.
18. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology 1996; 34: 953-958.
19. Bessen D, Fischetti V. Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. Journal of Experimental Medicine 1990; 172: 1757-1764.
20. Bessen D, et al. Genetic correlates of throat and skin isolates of group A streptococci. Journal of Infectious Diseases 1996; 173: 896-900.
21. McGregor KF, et al. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. Journal of Bacteriology 2004; 186: 4285-4294.
22. Svensson MD, Sjobring U, Bessen DE. Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo. Infection and Immunity 1999; 67: 3915-3920.
23. McKay FC, et al. Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infection and Immunity 2004; 72: 364-370.
24. Dicuonzo G, et al. Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy. Journal of Clinical Microbiology 2001; 39: 1687-1690.
25. Bessen DE, et al. Contrasting molecular epidemiology of group A streptococci causing tropical and non-tropical infections of the skin and throat. Journal of Infectious Diseases 2000; 182: 1109-1116.
26. McDonald M, et al. Recovering streptococci from the throat in remote tropical communities: A practical alternative to direct plating. Journal of Clinical Microbiology 2006; 44: 547-551.
27. Centers of Diseases Control and Prevention. Streptococcus laboratory (http://www.ede.gov/neidod/biotech/strep/strepindex.htm). Accessed 10 December 2006.
28. Johnson DR, et al. Characterization of group A streptococci (Streptococcus pyogenes): Correlation of M-protein and emm gene type with T-protein agglutination pattern and serum opacity factor. Journal of Medical Microbiology 2006; 55: 157-164.
29. Binns P, Markey P, Krause V. An outbreak of acute post-streptococcal glomerulonephritis in a remote Aboriginal community in 2005. Northern Territory Disease Control Bulletin 2005; 12 12-15.
30. Colman G, et al. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their associations with disease. Journal of Medical Microbiology 1993; 39: 165-178.
31. Fiorentino T, et al. A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. Journal of Infectious Diseases 1997; 176: 177-182.
32. Bessen D, et al. Serologic evidence for a Class 1 group A streptococcal infection among rheumatic fever patients. Journal of Infectious Diseases 1995; 172: 1608-1611.
33. Brandt ER, et al. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations. International Immunology 2001; 13: 1335-1343.
34. Tewodros W, Kronvall G. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. Journal of Clinical Microbiology 2005; 43: 4369-4376.
35. Sharma M, et al. Heterogeneity of community based pediatric GAS isolates from India: Challenges to the multivalent vaccine. In: Sriprakash KS, ed. Streptococci-New Insights into an Old Enemy. Amsterdam: Elsevier, 2006, pp. 49-53.
36. Dey N, et al. High diversity of group A Streptococcal emm types in an Indian community: The need to tailor multivalent vaccines. Clinical Infectious Diseases 2005; 40: 46-51.
37. Kearns T, Evans C, Krause V. Outbreak of acute post streptococcal glomerulonephritis in the Northern Territory-2000. Northern Territory Disease Control Bulletin 2001; 8: 6-13.
38. Potter E, et al. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. Journal of Pediatrics 1978; 92: 325-333.
39. Dillon H. Post-streptococcal glomerulonephritis following pyoderma. Reviews of Infectious Diseases 1979; 1: 935-945.
40. Majeed HA, et al. The concurrent associations of group A streptococcal serotypes in children with acute rheumatic fever or pharyngitis-associated glomerulonephritis and their families in Kuwait. Zentralblat Bakteriologie Mikrobiologie Hygiene 1986; 262: 346-356.
41. Shelburne SA, et al. Maltodextrin utilization plays a key role in the ability of group A streptococcus to colonize the oropharynx. Infection and Immunity 2006; 74: 4605-4614.
42. Anthony B, et al. The dynamics of streptococcal infections in a defined population of children: Serotypes associated with skin and respiratory infections. American Journal of Epidemiology 1976; 104: 652-666.
43. Currie B. Group A streptococcal infections of the skin: Molecular advances but limited therapeutic progress. Current Opinion in Infectious Diseases 2006; 19: 132-138.
44. Kalia A, et al. Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infection and Immunity 2002; 70: 1971-1983.